The decision — centering on the gene-editing technology CRISPR and its initial cutting protein, called Cas9 — shifts the invention of the system to two other institutions.University of California loses breakthrough CRISPR patent in PTO ruling
The decision — centering on the gene-editing technology CRISPR and its initial cutting protein, called Cas9 — shifts the invention of the system to two other institutions.